LIPOFABRIK

Their core work

LIPOFABRIK is a French biotech SME specializing in the production of lipopeptides — biomolecules with natural pest control properties. Their core platform technology enables the manufacturing of bio-based alternatives to chemical pesticides, targeting safer and more sustainable crop protection. They also contribute expertise in bio-based materials for food packaging applications, connecting their biomolecular know-how to food preservation challenges.

What they specialise in

How they've shifted over time

LIPOFABRIK's H2020 trajectory follows a textbook SME growth path. They entered as a consortium participant in BIOSMART (2017), contributing bio-based expertise to a food packaging project, then launched their own core technology through the SME Instrument — first a feasibility study (Phase 1, 2018) and then a full innovation project (Phase 2, 2019-2021). This progression shows a company that validated its biopesticide production platform and secured significant EU funding to bring it closer to market.

LIPOFABRIK is moving from R&D participation toward commercializing their proprietary lipopeptide production platform for the agricultural biopesticides market.

How they like to work

LIPOFABRIK operates primarily as a project leader — coordinating 2 of their 3 H2020 projects, both centered on their own technology. Their SME Instrument projects were single-company efforts (typical for the scheme), while their participation in BIOSMART shows they can also contribute as a specialist partner in larger consortia. With 11 unique partners across 8 countries, they have built a respectable network for a small company with only 3 projects.

Despite being a small company, LIPOFABRIK has collaborated with 11 different partners across 8 countries, mainly through the BIOSMART consortium. Their network spans multiple European countries, reflecting the international nature of the bio-based industries sector.

What sets them apart

LIPOFABRIK occupies a niche at the intersection of biotechnology and agriculture — producing lipopeptide-based biopesticides as alternatives to synthetic chemicals. Their successful SME Instrument Phase 1 to Phase 2 progression signals that EU evaluators validated both their technology and their business case. For consortium builders, they bring a proprietary biomolecular production platform that can contribute to projects in sustainable agriculture, food safety, and bio-based products.

Highlights from their portfolio

• Lipofabrik
  SME Instrument Phase 2 project with EUR 1.59M funding — their largest grant, focused on commercializing their biopesticide production platform.
• BIOSMART
  Bio-Based Industries consortium project on smart food packaging, where LIPOFABRIK contributed biomolecular expertise alongside international partners.